It upregulated the expression of its target gene TIM-3 by degrading miR-449c-5p, thereby inhibiting NK cell function, promoting immune escape of HCC, and driving resistance to PD1 immunotherapy. The gene discussed is HAVCR2; the disease is hepatocellular carcinoma.